Walgreen faces off with the DEA over painkiller distribution

03/20/2013 | Miami Herald (free registration), The

Walgreen is appealing an order by the DEA to suspend shipments of controlled substances, such as oxycodone, from its Jupiter, Fla., distribution center in a case before the U.S. Court of Appeals in Washington, D.C., on Thursday. The DEA claims that the center, one of Walgreen's 13 nationwide, has a history of filling suspicious drug orders and is a public safety threat. In a brief, Walgreen said, "This case involves an abuse of the extraordinary power that the Drug Enforcement Administration wields over ordinary citizens and businesses."

View Full Article in:

Miami Herald (free registration), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ